Please provide a comparison chart of neurologic medications for study, highlighting key differences and contraindications.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Neurologic Medication Comparison Chart

Antiepileptic/Antiseizure Medications

First-Line Agents for Seizure Management

Medication Loading Dose Maintenance Dose Route Key Advantages Major Contraindications Critical Adverse Effects
Levetiracetam [1,2] 1,500 mg oral or up to 60 mg/kg IV 500-1,500 mg BID PO/IV Preferred first-line: No drug interactions, no hepatotoxicity, rapid loading Hypersensitivity Psychiatric effects (agitation, depression), fatigue, dizziness
Lamotrigine [1,2] 6.5 mg/kg single dose (only if on >6 months without rash) Titrate slowly to 200-400 mg/day PO Good efficacy, well-tolerated long-term History of rash, pregnancy concerns, not previously on lamotrigine Serious rashes (Stevens-Johnson syndrome), requires slow titration
Phenytoin [1] 20 mg/kg divided (max 400 mg q2h) or 18 mg/kg IV (max 50 mg/min) 300-400 mg/day PO/IV Established efficacy, oral option available Cardiac conduction abnormalities, hypersensitivity Hypotension, bradyarrhythmias, cardiac arrest, extravasation injuries (IV), gingival hyperplasia
Fosphenytoin [1] 18 PE/kg IV (max 150 PE/min) Convert to phenytoin equivalent IV/IM Fewer adverse events than phenytoin IV, IM option Same as phenytoin Less local irritation than phenytoin
Valproate [1,2] Up to 30 mg/kg IV (max 10 mg/kg/min) 600-1,500 mg/day divided PO/IV Broad spectrum efficacy Pregnancy (teratogenic), liver disease, thrombocytopenia, females of childbearing potential Hepatotoxicity, thrombocytopenia, weight gain, tremor

Second-Line/Adjunctive Agents

Medication Starting Dose Maximum Dose Route Indications Contraindications Key Adverse Effects
Gabapentin [1,3] 100-300 mg at bedtime or TID 3,600 mg/day divided PO Adjunct for partial seizures, neuropathic pain Hypersensitivity Somnolence, dizziness, ataxia, fatigue; requires renal adjustment
Pregabalin [3] 50 mg TID or 75 mg BID 600 mg/day (200 mg TID) PO Adjunct for partial seizures, neuropathic pain Hypersensitivity Dizziness, somnolence, memory/concentration impairment; requires renal adjustment
Lacosamide [1,2] Studied but loading not established Titrate to therapeutic dose PO/IV Adjunct for partial seizures Cardiac conduction abnormalities Dizziness, headache, withdrawal seizures with abrupt discontinuation
Carbamazepine [1,4] 8 mg/kg oral suspension 800-1,200 mg/day PO Focal seizures, neuropathic pain Bone marrow suppression, cardiac conduction defects, MAO inhibitor use Drowsiness, nausea, dizziness, enzyme inducer (multiple drug interactions)
Topiramate [5,6] 25-50 mg/day 200-400 mg/day PO Migraine prevention, seizures Pregnancy, nephrolithiasis, glaucoma Cognitive impairment, paresthesias, weight loss, metabolic acidosis

Neuropathic Pain Medications

First-Line Agents 3, 4

Medication Class Agent Starting Dose Target Dose Duration of Trial Contraindications Key Adverse Effects
TCAs (Secondary Amines) Nortriptyline, Desipramine 25 mg at bedtime 75-150 mg/day 6-8 weeks (2 weeks at max dose) Cardiac disease, recent MI, arrhythmias, age >40 requires ECG Anticholinergic effects, orthostasis, cardiac conduction abnormalities, sudden death >100 mg/day
SNRIs Duloxetine 30 mg daily × 1 week 60-120 mg/day 4 weeks Uncontrolled hypertension, hepatic/renal insufficiency, MAO inhibitor use Nausea (transient), somnolence, dizziness
Venlafaxine 37.5 mg daily or BID 150-225 mg/day 4-6 weeks Cardiac disease (caution) Cardiac conduction abnormalities, hypertension, withdrawal syndrome
Calcium Channel α2δ Ligands Gabapentin 100-300 mg at bedtime 1,800-3,600 mg/day divided 3-8 weeks titration + 2 weeks at max Renal insufficiency (adjust dose) Dizziness, sedation, peripheral edema
Pregabalin 50 mg TID or 75 mg BID 300-600 mg/day 4 weeks Renal insufficiency (adjust dose) Dizziness, sedation, weight gain, peripheral edema

Alzheimer's Disease/Dementia Medications 7

Cholinesterase Inhibitors

Medication Starting Dose Maximum Dose Frequency Contraindications Key Adverse Effects Notes
Donepezil 5 mg/day 10 mg/day Once daily Hypersensitivity, cardiac conduction defects Nausea, vomiting, diarrhea (take with food), initial agitation Not hepatotoxic, longest half-life
Rivastigmine 1.5 mg BID 6-12 mg/day Twice daily Hypersensitivity Nausea, vomiting, diarrhea, weight loss, headache, dizziness Higher doses more effective, no lab monitoring
Galantamine 4 mg BID with meals 12 mg BID Twice daily Severe hepatic/renal impairment Nausea, vomiting, diarrhea (take with meals) Gradual titration reduces GI effects
Tacrine Variable Variable Four times daily Hepatotoxicity Hepatotoxicity, requires monitoring Rarely used due to toxicity

Behavioral Management Agents 7

Drug Class Agent Starting Dose Maximum Dose Indications Contraindications Key Warnings
Atypical Antipsychotics Risperidone 0.25 mg at bedtime 2-3 mg/day Delusions, hallucinations, severe agitation Hypersensitivity, dementia-related psychosis (black box) Extrapyramidal symptoms at ≥2 mg/day
Olanzapine 2.5 mg at bedtime 10 mg/day Same as above Same as above Generally well tolerated, metabolic effects
Quetiapine 12.5 mg BID 200 mg BID Same as above Same as above More sedating, transient orthostasis
Mood Stabilizers Trazodone 25 mg/day 200-400 mg/day Agitation, insomnia Premature ventricular contractions Use with cardiac caution
Divalproex 125 mg BID Titrate to level 40-90 mcg/mL Severe agitation, combativeness Pregnancy, liver disease Better tolerated than carbamazepine, monitor LFTs

Migraine Prevention Medications 5, 6

Recommended Treatment Hierarchy

First-Tier (Use Before CGRP Agents) 5:

Medication Starting Dose Target Dose Contraindications Key Adverse Effects
β-Blockers
Metoprolol 50 mg BID 100-200 mg/day Asthma, cardiac failure, AV block, Raynaud disease Fatigue, bradycardia, hypotension
Propranolol 80 mg/day (long-acting) 160 mg/day Same as above Same as above
Antiseizure
Valproate 250 mg BID 600-1,500 mg/day Pregnancy (teratogenic), liver disease, females of childbearing potential Tremor, weight gain, hair loss, hepatotoxicity
SNRI
Venlafaxine 37.5 mg daily 150-225 mg/day Uncontrolled hypertension, cardiac disease Nausea, hypertension, withdrawal syndrome
TCA
Amitriptyline 10 mg at bedtime 50-100 mg/day Cardiac disease, glaucoma, age >40 requires ECG Anticholinergic effects, weight gain, sedation

Second-Tier (After First-Tier Trial Failure) 5:

  • CGRP antagonist-gepants (atogepant, rimegepant)
  • CGRP-mAbs (eptinezumab, erenumab, fremanezumab, galcanezumab)

Third-Tier (After Above Failures) 5:

  • Topiramate: 25-50 mg/day → 100-200 mg/day (contraindicated in pregnancy, nephrolithiasis)

Critical Contraindications Summary

Absolute Contraindications by Condition

Pregnancy/Childbearing Potential:

  • NEVER use: Valproate (teratogenic) 2, 4, 6
  • Avoid: Topiramate, carbamazepine, lamotrigine (unless specialist supervised) 6
  • Safest options: Levetiracetam (seizures), propranolol or amitriptyline (migraine, specialist supervision) 6

Cardiac Disease:

  • Avoid: TCAs (especially >100 mg/day), venlafaxine, β-blockers (if heart failure/AV block) 3, 6
  • Require ECG: All patients >40 years before starting TCAs 3

Hepatic Disease:

  • Contraindicated: Valproate, tacrine 7, 4
  • Caution: Duloxetine, carbamazepine

Renal Insufficiency:

  • Require dose adjustment: Gabapentin, pregabalin, levetiracetam 1, 3

Psychiatric Disease:

  • Caution with: Levetiracetam (aggression, depression), topiramate (cognitive effects), SSRIs/SNRIs (bipolar disorder, suicidal ideation) 1, 8

Drug Interaction Warnings

Enzyme-Inducing Antiepileptics (AVOID in Cancer/Complex Patients) 9, 2:

  • Phenytoin, carbamazepine, phenobarbital: Induce metabolism of chemotherapy, steroids, hormonal contraceptives
  • Preferred alternatives: Levetiracetam, lamotrigine, valproate

Serotonin Syndrome Risk 10:

  • Dangerous combinations: SSRIs/SNRIs + MAO-B inhibitors (selegiline, rasagiline) or triptans
  • Contraindicated: Concurrent MAO inhibitor use with any SSRI/SNRI 8

Anticonvulsant Prophylaxis in Brain Tumors 9, 2:

  • NOT recommended: Primary prophylaxis (no seizure history)
  • Recommended: Only after documented seizure
  • First choice: Levetiracetam (no drug interactions) 2
  • Avoid: Enzyme-inducing agents (phenytoin, carbamazepine) 2

Special Population Considerations

Elderly Patients:

  • Start all medications at lower doses with slower titration 3
  • Avoid typical antipsychotics (50% develop tardive dyskinesia after 2 years) 7
  • Benzodiazepines: Use lowest effective dose, short half-life agents only 7

Pregnancy/Lactation:

  • Acute migraine: Paracetamol first-line; NSAIDs second trimester only; sumatriptan under specialist only 6
  • Seizures: Continue levetiracetam or lamotrigine if needed; never valproate 6
  • Breastfeeding: Paracetamol, ibuprofen, sumatriptan, propranolol considered safe 6

References

6
Guideline

diagnosis and management of migraine in ten steps.

Nature Reviews Neurology, 2021

8
Guideline

treatment of symptoms of the menopause: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2015

Related Questions

A patient taking an antiseizure medication and escitalopram reports a persistent sensation of feeling hot; what are the possible causes and how should this be evaluated and managed?
How should I evaluate and manage a 55-year-old female with a 20-year history of seizure disorder who is taking phenytoin 100 mg twice daily and phenobarbital 60 mg twice daily, has a low body weight of 38 kg, borderline hypotension (90/60 mm Hg), normal SpO₂ (98 %) and pulse (90 bpm)?
What is the first‑line antiepileptic drug for a 26‑year‑old woman with a witnessed generalized tonic‑clonic seizure, a four‑year history of epilepsy, not currently on any antiepileptic medication, primary generalized tonic‑clonic seizures, no clinical features of juvenile myoclonic epilepsy, and a normal electroencephalogram?
How does escitalopram contribute to nightmares and vivid dreams, and will a slow taper of escitalopram reduce these sleep disturbances in a patient already taking lamotrigine 25 mg nightly?
What is the most appropriate antiseizure medication for a patient with tonic-clonic epilepsy and a history of kidney transplant, hypertension, hyperlipidemia, insomnia, and atrial fibrillation, taking verapamil, apixaban, tacrolimus, azathioprine, daridorexant, simvastatin, and lisinopril?
Is primidone an appropriate first-line therapy for essential tremor, and what dosing and monitoring are recommended?
Is dapagliflozin (Farxiga) appropriate for a patient with type 2 diabetes?
What is the potentially lethal oral dose of oxycodone in an opioid‑naïve adult?
I have been on lurasidone (Latuda) 40 mg and reduced to 10 mg for 22 days; when can I expect to feel better?
What are the contraindications for progesterone therapy?
I turned my head and felt a popping sensation in my neck followed by facial flushing; could this indicate a cervical artery dissection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.